FY2026 · ended Mar 31, 2026 · Revenue $1.14M, +0.8% YoY · Filed Jun 29, 2026
PetVivo Holdings, Inc. (PETV) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2026, which ended Mar 31, 2026, it reported revenue of $1.1 million and a net loss of $10.5 million. Free cash flow was -$6.1 million. As of Jun 30, 2026 it held $122,633 in cash and investments and $38,654 in total debt.
Revenue (TTM)
$1.18M
-9.5% vs year-ago TTM
Net income (TTM)
$-9.78M
-12.9% vs year-ago TTM
Operating cash flow (TTM)
$-5.44M
-0.3% vs year-ago TTM
Free cash flow (TTM)
$-5.44M
EPS (TTM)
$-0.29
+25.9% vs year-ago TTM
Dividend per share
None
Shares outstanding
37.59M
+54.1% vs prior year
Net cash
$83,979
as of Jun 30, 2026
Operating margin
-747.0%
FY 2027
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- PETV (OTC)
- Fiscal year ends
- March 31
- Incorporated in
- NV
- Headquarters
- Edina, MN
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1512922
- Former names
- Technologies Scan Corp (until May 2, 2014)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2026 Mar 31, 2026 |
FY 2025 Mar 31, 2025 |
FY 2024 Mar 31, 2024 |
FY 2023 Mar 31, 2023 |
FY 2022 Mar 31, 2022 |
|---|---|---|---|---|---|
| Revenue | $1.1M | $1.1M | $968,706 | $917,162 | $115,586 |
| Operating income | -$9.1M | -$8.1M | -$10.6M | -$8.7M | -$5.1M |
| Net income | -$10.5M | -$8.4M | -$11.0M | -$8.7M | -$5.0M |
| Diluted EPS | -$0.38 | -$0.41 | -$0.78 | — | — |
| Operating cash flow | -$6.1M | -$5.3M | -$7.4M | -$6.8M | -$4.2M |
| Free cash flow | -$6.1M | -$5.4M | -$7.7M | -$7.2M | -$4.3M |
| Total assets | $3.6M | $9.3M | $3.1M | $2.4M | $7.4M |
| Total liabilities | $1.4M | $5.1M | $2.4M | $1.7M | $1.4M |
| Stockholders' equity | $2.2M | $4.2M | $685,953 | $725,025 | $6.0M |
| Cash and investments | $350,782 | $227,689 | — | — | — |
| Total debt | $54,711 | $962,000 | $1.2M | $317,981 | $299,101 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Sep 22, 2026 | Sep 22, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 22, 2026 | Sep 22, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 20, 2026 | Aug 20, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Agreement ended, Regulation FD disclosure
|
Jul 29, 2026 | Jul 24, 2026 |
| 8-K |
Current report
Auditor change
|
Jul 27, 2026 | Jul 23, 2026 |
All 697 PetVivo Holdings, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.